FDA Fails to Inspect Drug Factory After Multiple Recalls

The FDA has not inspected Glenmark Pharmaceuticals' factory in India despite seven recalls of potassium chloride capsules due to improper dissolution, which poses a potentially deadly risk. The FDA's last inspection was over four years ago, and the agency has been criticized for its slow response and inadequate oversight of foreign drug manufacturers. The recalls have been linked to several deaths and hospitalizations, highlighting systemic issues in the FDA's regulation of generic drugs produced overseas.